BGI Genomics Co Ltd banner

Intrinsic Value

The intrinsic value of BGI Genomics Co Ltd (300676) under the Base Case is 40.7 CNY per share. Compared with the current market price of 40.9 CNY, the stock appears Fairly Valued .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

Intrinsic Value
¥40.7
Fairly Valued
Intrinsic Value
Price ¥40.9

BGI Genomics Co Ltd is cheaper than usual. Its valuation was this low or lower on just 15% of days in the past 5 years.

Monitor BGI Genomics Co Ltd
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value ¥32.56
Get notified when the price drops into your buy zone
Current Price ¥40.9
Intrinsic Value ¥40.7
Margin of Safety 20% ¥32.56
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to BGI Genomics Co Ltd

Fundamental Analysis

What BGI Genomics Does

Biotechnology Health Care

BGI Genomics Co Ltd is a genetics testing and sequencing company. It sells lab tests and related services that read DNA and analyze biological samples for hospitals, clinics, public health agencies, and research groups. Its work covers areas like prenatal and reproductive testing, cancer and disease screening, infectious disease detection, and research support for scientists.

Headquarters
China CN
Employees
4 333
IPO date
Jul 14, 2017
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
BGI Genomics Co Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one BGI Genomics Co Ltd stock?

The intrinsic value for BGI Genomics Co Ltd (300676) under the Base Case is 40.7 CNY.

Is BGI Genomics Co Ltd stock undervalued or overvalued?

Compared with the current market price of 40.9 CNY, the stock appears Fairly Valued .

Back to Top